"/> STEMCELL Technologies Nocodazole | B-LABO France

STEMCELL Technologies Nocodazole

Réf. : BL-RE-126706Réf. fabricant : 17140322 50 mg
594,00 € HT

Microtubule polymerization inhibitor; Inhibits beta-tubulin

CAS
31430-18-9
Synonyme
NSC 238159; Oncodazole; R 17934
Quantité
50 mg
Formule moléculaire
C14H11N3O3S
Pureté
≥98%
Marque
STEMCELL Technologies

Caractéristiques principales

  • Nocodazole is an anti-mitotic agent that reversibly interferes with the polymerization of microtubules (De Brabander et al.) Nocodazole binds to beta-tubulin and disrupts microtubule assembly/disassembly dynamics, impairing formation of the metaphase spindles during the cell division cycle
  • This prevents mitosis by inducing a G2/M-phase arrest and induces apoptosis in tumor cells (Jordan et al.)
  • Synchronizes human pluripotent stem cells (hPSCs) in the G2/M cell cycle phase, thereby increasing the efficiency of homology-directed repair (HDR) in CRISPR-Cas9 genome editing (Lin et al.; Yang et al.)
  • Induces apoptosis in leukemic cells without harming T cells and/or mesenchymal stromal cells that were recovered from the same patients (Frezzato et al.)

Caractéristiques techniques

MarqueSTEMCELL Technologies
Réf. B-LABOBL-RE-126706
Réf. fabricant17140322
CAS31430-18-9
SynonymeNSC 238159; Oncodazole; R 17934
Quantité50 mg
Formule moléculaireC<sub>14</sub>H<sub>11</sub>N<sub>3</sub>O<sub>3</sub>S
Pureté≥98%
Une question, une configuration particulière ?
Contactez-nous pour un devis.